Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.
Clinical trial NCT06145048 · COMPLETED
Trial details
- NCT number
- NCT06145048
- Sponsor
- Vergent Bioscience, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-05
- Primary completion
- 2024-10-31
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.